Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q3 EPS of ($0.19), $0.09 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.